These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 11170858)

  • 41. Th1/Th2 balance in the liver and hepatic lymph nodes of vaccinated and unvaccinated sheep during acute stages of infection with Fasciola hepatica.
    Pacheco IL; Abril N; Morales-Prieto N; Bautista MJ; Zafra R; Escamilla A; Ruiz MT; Martínez-Moreno A; Pérez J
    Vet Parasitol; 2017 Apr; 238():61-65. PubMed ID: 28385539
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Epidemiology and Control of Liver Flukes in Cattle and Sheep.
    Howell AK; Williams DJL
    Vet Clin North Am Food Anim Pract; 2020 Mar; 36(1):109-123. PubMed ID: 32029178
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The biotechnology-value chain: development of Sm14 as a schistosomiasis vaccine.
    Tendler M; Simpson AJ
    Acta Trop; 2008; 108(2-3):263-6. PubMed ID: 18834847
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Unusual transmission of the liver fluke, Fasciola hepatica, by Lymnaea glabra or Planorbis leucostoma in France.
    Abrous M; Rondelaud D; Dreyfuss G; Cabaret J
    J Parasitol; 1998 Dec; 84(6):1257-9. PubMed ID: 9920323
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Progress in the development of Fasciola hepatica vaccine using recombinant fatty acid binding protein with the adjuvant adaptation system ADAD.
    López-Abán J; Casanueva P; Nogal J; Arias M; Morrondo P; Diez-Baños P; Hillyer GV; Martínez-Fernández AR; Muro A
    Vet Parasitol; 2007 Apr; 145(3-4):287-96. PubMed ID: 17275191
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vaccines against the zoonotic trematodes Schistosoma japonicum, Fasciola hepatica and Fasciola gigantica.
    McManus DP; Dalton JP
    Parasitology; 2006; 133 Suppl():S43-61. PubMed ID: 17274848
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The development of an experimental vaccine against Fasciola hepatica in cattle.
    Hall RF; Lang BZ
    Proc Annu Meet U S Anim Health Assoc; 1978; (82):56-60. PubMed ID: 287115
    [No Abstract]   [Full Text] [Related]  

  • 48. Proteolytic activity in Fasciola hepatica is reduced by the administration of cathepsin L mimotopes.
    Villa-Mancera A; Quiroz-Romero H; Correa D; Alonso RA
    J Helminthol; 2011 Mar; 85(1):51-5. PubMed ID: 20416126
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stimulation of resistance to Fasciola hepatica infection in sheep by a regime involving the use of the immunomodulatory compound L tetramisole (levamisole).
    Mitchell GB; Armour J
    Res Vet Sci; 1981 May; 30(3):343-8. PubMed ID: 7255928
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fasciola hepatica: a review of the economic impact in cattle and considerations for control.
    Kaplan RM
    Vet Ther; 2001; 2(1):40-50. PubMed ID: 19753697
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vaccination of sheep against Fasciola hepatica with homologous fatty acid binding proteins.
    Ramajo V; Oleaga A; Casanueva P; Hillyer GV; Muro A
    Vet Parasitol; 2001 May; 97(1):35-46. PubMed ID: 11337125
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Pathological changes of liver in infection of Fasciola hepatica].
    Gajewska A; Smaga-Kozłowska K; Wiśniewski M
    Wiad Parazytol; 2005; 51(2):115-23. PubMed ID: 16838620
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fasciola and fasciolosis in ruminants in Europe: Identifying research needs.
    Beesley NJ; Caminade C; Charlier J; Flynn RJ; Hodgkinson JE; Martinez-Moreno A; Martinez-Valladares M; Perez J; Rinaldi L; Williams DJL
    Transbound Emerg Dis; 2018 May; 65 Suppl 1(Suppl 1):199-216. PubMed ID: 28984428
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fasciola hepatica procathepsin L3 protein expressed by a baculovirus recombinant can partly protect rats against fasciolosis.
    Reszka N; Cornelissen JB; Harmsen MM; Bieńkowska-Szewczyk K; de Bree J; Boersma WJ; Rijsewijk FA
    Vaccine; 2005 Apr; 23(23):2987-93. PubMed ID: 15811644
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of Reproductive Histology Response of Adult
    Villa-Mancera A; Maldonado-Hidalgo J; Robles-Robles M; Olivares-Pérez J; Olmedo-Juárez A; Rodríguez-Castillo J; Pérez-Mendoza N; Utrera-Quintana F; Pérez J; Ortega-Vargas S
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000332
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Attempted immunisation of sheep against Fasciola hepatica using gamma-irradiated metacercariae.
    Creaney J; Spithill TW; Thompson CM; Wilson LR; Sandeman RM; Parsons JC
    Int J Parasitol; 1995 Jul; 25(7):853-6. PubMed ID: 7558572
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immuno-diagnosis of bubaline fasciolosis with Fasciola gigantica cathepsin-L and recombinant cathepsin L 1-D proteases.
    Raina OK; Yadav SC; Sriveny D; Gupta SC
    Acta Trop; 2006 May; 98(2):145-51. PubMed ID: 16647680
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The occurrence of fasciola hepatica in chosen regions of Poland based on molecular and serological methods].
    Kozak-Cieszczyk M
    Wiad Parazytol; 2006; 52(2):137-9. PubMed ID: 17120997
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A mucin-like peptide from Fasciola hepatica induces parasite-specific Th1-type cell immunity.
    Noya V; Brossard N; Berasaín P; Rodríguez E; Chiale C; Mazal D; Carmona C; Freire T
    Parasitol Res; 2016 Mar; 115(3):1053-63. PubMed ID: 26637311
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low allelic diversity in vaccine candidates genes from different locations sustain hope for Fasciola hepatica immunization.
    Dominguez MF; González-Miguel J; Carmona C; Dalton JP; Cwiklinski K; Tort J; Siles-Lucas M
    Vet Parasitol; 2018 Jul; 258():46-52. PubMed ID: 30105977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.